Drug Boosts Survival in Recurrent Ovarian Cancer
New clinical data showed an experimental drug called pertuzumab prolonged the survival time for women with recurrent ovary cancer, a University of Alabama at Birmingham doctor said recently. The data was presented Sept. 24 during a scientific session of the 14th European Cancer Conference held in Barcelona, Spain. The session’s main speaker was Sharmila Makhija, M.D., an associate professor in UAB’s Division of Gynecologic Oncology……..
Original post by Health news from medicineworld.org
No comments yet. Be the first.
Leave a reply
Drug Boosts Survival in Recurrent Ovarian Cancer
New clinical data showed an experimental drug called pertuzumab prolonged the survival time for women with recurrent ovary cancer, a University of Alabama at Birmingham doctor said recently. The data was presented Sept. 24 during a scientific session of the 14th European Cancer Conference held in Barcelona, Spain. The session’s main speaker was Sharmila Makhija, M.D., an associate professor in UAB’s Division of Gynecologic Oncology……..
Original post by Health news from medicineworld.org
No comments yet. Be the first.
Leave a reply